Welcome, how can we help?
Policy Types
Getting Technical
Home / News / 'Parkinson's drug could treat cancer'
'Parkinson's drug could treat cancer'
14 March 2008 17:18:34
Medical News Today reports that scientists believe dopamine, a drug currently used to treat Parkinson's disease and other illnesses, could possibly prevent new blood vessels from growing and slow cancer progression - a finding which may affect the life insurance policies of sufferers.
"Sometimes new drugs may not be the answer. We looked instead at a novel use for an established product and have found very promising results," said Dr Sujit Basu who conducted the research at the National Cancer Institute in Calcutta, India.
The study, which involved mice and laboratory models, has not been replicated in humans, but the results are encouraging, he added.
Dr Basu has been studying the role of dopamine in cancer for several years.
His research is currently based on mouse and laboratory models of sarcoma, a malignant tumor that affects soft tissues.
The study is published in the March 13 online issue of t he Journal of Clinical Investigation.
According to Cancer Research UK, 284,560 persons were diagnosed with cancer in the UK in 2004.
Direct Life and Pensions Services Ltd are one of the UK's leading providers of life insurance, term life assurance, mortgage protection, critical illness and life insurance advice online
News Archive
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007